Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Selarsdi (ustekinumab-aekn), a Biosimilar to Stelara
(BUSINESS WIRE) April 16, 2024 --Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...
Fasenra Approved for Treatment of Children Aged 6 to 11 with Severe Asthma
(BUSINESS WIRE) April 11, 2024 --AstraZeneca’s Fasenra® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on...
Xcopri (cenobamate) Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube
SK Life Science, Inc., a U.S. pharmaceutical company developing treatments that will change the future of central nervous system (CNS) disorders...
Lower Risk for MCI, Dementia Seen With Cognitively Stimulating Occupations
Individuals with a history of cognitively stimulating occupations from ages 30 to 65 years have lower risk for mild cognitive impairment (MCI) and dementia...
Mortality Risks Up for Women With Adverse Pregnancy Outcomes
Women who experience any of five major adverse pregnancy outcomes have increased mortality risks, which remain elevated during long-term follow-up, according...
Seven in 10 Experiencing Homelessness Have a Mental Health Disorder
The majority of people experiencing homelessness have mental health disorders, according to a review published online April 17 in JAMA Psychiatry.Rebecca...
Reports of Injuries, Deaths Prompt FDA to Recall Heart Failure Devices
The HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories, are now under a strict U.S. Food and Drug Administration...
Most Homeless Americans Are Battling Mental Illness
Two-thirds of homeless people are experiencing some form of mental health disorder, a large, new review of data on the subject. The analysis found that...
FDA Recalls Heart Failure Devices Linked to Injuries and Deaths
Two implanted heart devices used by patients in end-stage heart failure are now under a strict U.S. Food and Drug Administration recall, after being tied...
COVID Does Not Spur Asthma in Kids, Study Finds
There’s no evidence that a COVID infection increases the risk of asthma in children, the first study to date on the subject finds. “We knew...
Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials
Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug...
Walking Your Way to Better Health
Walking is one of the best exercises available to average folks, and it can be as easy as stepping out your front door, experts say. “It is something...
Counterfeit Versions of Botox Found in Multiple States
FDA is alerting health care professionals and consumers that unsafe counterfeit versions of Botox (botulinum toxin) have been found in multiple states...
Arrivo Bio Initiates Large Phase 2b Clinical Trial in Major Depressive Disorder with Novel SIRT6 Activator SP-624
(BUSINESS WIRE) April 16, 2024 -- Arrivo BioVentures announced today a significant step forward in the fight against major depressive disorder (MDD) with...
TLX101-CDx (Pixclara) Granted FDA Fast Track Designation
Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation1 for the Company’s...
Recently Added
Recently added consumer and prescribing information: Risvan, Voydeya, Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne, Wyost
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Selarsdi Selarsdi (ustekinumab-aekn) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
- Zevtera Zevtera (ceftobiprole medocaril) is a cephalosporin antibiotic for the treatment of bacteremia, acute bacterial skin and skin structure...
- Risvan Risvan (risperidone) is an atypical antipsychotic indicated for the treatment of schizophrenia in adults.
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
- Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.